Announcements Trials
Browse Landscape

Phase

Phase 2/3 1Phase 2 1

Status

Terminated 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Head & Neck 1Gynecologic 1Genitourinary 1

Conditions

Multiple Myeloma 7Pain, Postoperative 5Pain 4Parkinson Disease 4, Autosomal Dominant Lewy Body 3Burkitt Lymphoma 3Prostatic Neoplasms 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Neoplasms 2Neoplasm Metastasis 2Lymphoma, Non-Hodgkin 2Lymphoma 2Lung Neoplasms 2Leukemia, Hairy Cell 2Hodgkin Disease 2Carcinoma, Non-Small-Cell Lung 2Carcinoma in Situ 2Breast Neoplasms 2Agnosia 2Vulvar Neoplasms 1Vulvar Diseases 1Uterine Cervical Neoplasms 1Uterine Cervical Dysplasia 1Urinary Bladder Neoplasms 1Triple Negative Breast Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Skin Neoplasms 1Sarcoma, Alveolar Soft Part 1Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1Papillomavirus Infections 1Ovarian Neoplasms 1

Interventions

Bupivacaine 4Saline Solution 3Ketamine 3Transcutaneous Electric Nerve Stimulation 2Ropivacaine 2Radiofrequency Ablation 2Magnesium Sulfate 2Ketorolac 2Dexmedetomidine 2Control Groups 2Anesthesia, Local 2Acupuncture Therapy 2Acetaminophen 2engage 8200 1Yoga 1Varenicline 1Transdermal Patch 1Therapeutics 1Telemedicine 1Surgical Instruments 1STAMP-I protocol 1Radiosurgery 1Psilocybin 1Palliative Care 1Oxycodone 1Music Therapy 1Morphine 1Methods 1Levobupivacaine 1Ketoprofen 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Agnosia × Acetaminophen × 1 year × Clear all
NCT05597878 2026-06-01

Opioid-Free Pain Control Regimen Following Robotic Radical Prostatectomy

Wake Forest University Health Sciences

Phase 2/3 Terminated
58 enrolled
Genitourinary

Agnosia, Prostatic Neoplasms

NCT02439034 2026-03-16

KETOCOL

Centre Oscar Lambret

Phase 2 Completed
68 enrolled
GynecologicHead & Neck

Agnosia, Uterine Cervical Neoplasms, Head and Neck Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡